Checkpoint Therapeutics (CKPT)
(Delayed Data from NSDQ)
$1.43 USD
+0.01 (0.70%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.44 +0.01 (0.70%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 5/20/24 |
---|---|
Current Quarter | -0.37 |
EPS Last Quarter | -1.10 |
Last EPS Surprise | -48.65% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.34 |
Next Year | NA |
EPS (TTM) | -3.33 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.03M | 0.03M | 0.64M | NA |
# of Estimates | 1 | 1 | 2 | NA |
High Estimate | 0.03M | 0.03M | 1.17M | NA |
Low Estimate | 0.03M | 0.03M | 0.10M | NA |
Year ago Sales | 0.04M | 0.03M | 0.10M | 0.64M |
Year over Year Growth Est. | -25.00% | 0.00% | 516.50% | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.37 | -0.37 | -1.34 | NA |
# of Estimates | 1 | 1 | 3 | NA |
Most Recent Consensus | -0.37 | -0.37 | -1.38 | NA |
High Estimate | -0.37 | -0.37 | -1.13 | NA |
Low Estimate | -0.37 | -0.37 | -1.51 | NA |
Year ago EPS | -0.89 | -1.05 | -3.17 | -1.34 |
Year over Year Growth Est. | 58.43% | 64.76% | 57.73% | NA |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | NA |
Up Last 30 Days | 0 | 0 | 1 | NA |
Up Last 60 Days | 0 | 0 | 1 | NA |
Down Last 7 Days | 0 | 0 | 0 | NA |
Down Last 30 Days | 0 | 0 | 0 | NA |
Down Last 60 Days | 0 | 0 | 0 | NA |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.37 | -0.37 | -1.34 | NA |
7 Days Ago | -0.37 | -0.37 | -1.34 | NA |
30 Days Ago | -0.37 | -0.37 | -1.75 | NA |
60 Days Ago | NA | NA | -1.68 | NA |
90 Days Ago | NA | NA | -1.68 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.37 | -0.37 | -1.13 | NA |
Zacks Consensus Estimate | -0.37 | -0.37 | -1.34 | NA |
Earnings ESP | 0.00% | 0.00% | 15.67% | NA |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.10 | -0.29 | -1.05 | -0.89 | NA |
Estimate | -0.74 | -0.85 | -0.83 | -0.92 | NA |
Difference | -0.36 | 0.56 | -0.22 | 0.03 | 0.00 |
Surprise | -48.65% | 65.88% | -26.51% | 3.26% | -1.51% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more